实用医学杂志 ›› 2021, Vol. 37 ›› Issue (4): 428-433.doi: 10.3969/j.issn.1006⁃5725.2021.04.003

• 基础研究 • 上一篇    下一篇

组蛋白去乙酰化酶3抑制剂RGFP966改善放射性脑损伤的研究

任安邦, 李荣, 徐安安, 简海锋, 李可俊, 袁亚维   

  1. 广州医科大学附属肿瘤医院放疗科(广州 510095)
  • 出版日期:2021-02-25 发布日期:2021-02-25
  • 通讯作者: 袁亚维 E⁃mail:yuanyawei@gzhmu.edu.cn
  • 基金资助:
    国家自然科学基金项目(编号:81773354,81803170);广州市临床高新、重大和特色技术项目(编号:2019ZD17)

Selective Histone deacetylase 3 inhibitor RGFP966 alleviates radiation⁃induced brain injury

REN Anbang LI Rong,XU An′an,JIAN Haifeng,LI Kejun,YUAN Yawei   

  1. Department of Radiation Oncology,Affiliated Cancer Hospital of Guangzhou Medical University,Guangzhou 510095,China

  • Online:2021-02-25 Published:2021-02-25
  • Contact: YUAN Yawei E⁃mail:yuanyawei@gzhmu.edu.cn

摘要:

目的 探讨高度选择性的组蛋白去乙酰化酶 3(histone deacetylase 3,HDAC3)抑制剂 RGFP966 在治疗放射性脑损伤(radiation⁃induced brain injury,RBI)中的作用。方法 医用直线加速器放射 处理小胶质细胞系 BV2 或海马神经元细胞系 HT22,细胞免疫荧光观察放射后小胶质细胞激活指标 IBA⁃1 的表达情况;实时荧光定量 PCR 技术(qRT⁃PCR)和酶联免疫吸附法(Elisa)检测放射后小胶质细胞表达和 分泌的炎症因子水平;CCK-8 实验测定小胶质细胞系 BV2 和海马神经元细胞系 HT22 的细胞活力;TUNEL 实验检测放射后神经元凋亡的数量。结果 与单纯放射组比较,RGFP966+放射组的小胶质细胞 BV2 炎症因子(TNF⁃α /IL⁃6/IL⁃1β)mRNA 表达及其分泌均显著降低、神经元 HT22 细胞凋亡数量显著减少、BV2 HT22 细胞活力明显改善。小鼠放射性脑损伤模型中,RGFP966 可显著减少放射导致的海马神经元凋 亡。结论 HDAC3 抑制剂 RGFP966 可有效抑制放射后小胶质细胞介导的神经炎症并减少放射后神经元 的凋亡。因此,RGFP966具有治疗放射性脑损伤的应用潜力。

关键词:

Abstract:

Objective To investigate the function of RGFP966,a highly selective histone deacetylase 3 (HDAC3)inhibitor,in radiation ⁃induced neuroinflammation and neuronal injury. Methods Microglia cell line BV2 or hippocampal neuron cell line HT22 were radiated by a medical linear accelerator. The expression of microg⁃ lia activation indicator IBA⁃1 was observed by cellular immunofluorescence;the expression and secretion level of inflammatory cytokines in radiated microglia were detected by quantitative real ⁃ time reverse transcription polymerase chain reaction(qRT⁃PCR)or enzyme⁃linked immunosorbent assay(Elisa);the activity of BV2 cells and HT22 cells were detected by cell counting kit⁃8 assay;neuronal apoptosis was identified using TUNEL staining. Results RGFP966 dramatically reduced the secretion of inflammatory cytokines brought about by ionizing radiation(IR)in BV2 cells,including tumor necrosis factor α(TNF⁃α),interleukin 6(IL⁃6),and interleukin 1β(IL⁃1β). Pretreated with RGFP966 significantly reduced the number of apoptosis in radiated HT22 cells. Radia⁃ tion⁃induced impairment of the viability of BV2 cells and HT22 cells was also alleviated by RGFP966. In the mouse model of RBI,RGFP966 significantly reduced the number of neuronal apoptosis. Conclusion The selective HDAC3 inhibitor RGFP966 effectively alleviated microglial neuroinflammation and neuronal apoptosis caused by IR. Therefore,RGFP966 has the potential to treat radiation⁃induced brain injury.

Key words: ionizing radiation, radiation?induced brain injury, HDAC3 inhibitor